arrow
P

Petros P. Sfikakis

National and Kapodistrian University of Athens
H指数:74
被引数:2.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Baricitinib retention and factors associated thereof in clinical practice: a prospective, multicenter 12-month study in rheumatoid arthritis patients

巴瑞替尼的持续使用及其相关因素在临床实践中的研究:一项针对类风湿关节炎患者的多中心前瞻性12个月研究

2026-10-050
OAAI
Long-term remission and monocyclic course in Still's disease patients starting canakinumab early: data from the international AIDA network registry

早期开始使用卡那奴单抗的斯蒂尔病患者长期缓解和单周期病程:国际AIDA网络登记数据

2026-09-291
PRE
Real-World Safety and Effectiveness of JAK Inhibitors in Systemic Sclerosis: A Propensity-Matched Study From the EUSTAR Cohort

系统性硬化症中JAK抑制剂的实时安全性和有效性:来自EUSTAR队列的倾向性匹配研究

2026-09-080
OAAI
P25 - ECE_3587 - Ordinary circadian rhythm and physiological variation of diurnal salivary cortisol levels in healthy young adults

P25 - ECE_3587 - 健康年轻成年人唾液皮质醇日间水平昼夜节律的常规昼夜节律和生理变化

2026-08-100
OAAI
CRP at diagnosis in psoriatic arthritis: what it means and associations with long-term outcomes

银屑病关节炎诊断时的CRP:其意义及与长期预后的关联

2026-08-070
OAAI
Integrative assessment of high-sensitivity C-reactive protein and lipid levels in predicting 20-year atherosclerotic cardiovascular disease risk, in a Mediterranean population: The ATTICA study (2002-2022)

地中海人群中高敏C反应蛋白和血脂水平对预测20年动脉粥样硬化性心血管疾病风险的整合评估:ATTICA研究(2002-2022)

2026-08-010
PRE
Effectiveness and probability of full disease control with canakinumab in familial Mediterranean fever: real-world data from the AIDA Network

卡那奴单抗在家族性地中海热中的完全疾病控制有效性和概率:AIDA网络的真实世界数据

2026-07-130
PRE
Disease-related and psychosocial factors associated with difficult-to-manage and treatment-refractory axial spondyloarthritis: insights from the Greek AxSpA Registry

与难治性和治疗抵抗性轴性脊柱关节炎相关的疾病相关和心理社会因素:来自希腊AxSpA登记研究的见解

2026-07-080
PRE
Long-term safety and pulmonary function stabilization with nintedanib in systemic sclerosis-associated interstitial lung disease, 2020–2025: a real-world retrospective study from a reference centre

2020–2025年系统性硬化症相关间质性肺疾病患者使用尼达尼布的长期安全性和肺功能稳定性的真实世界回顾性研究:来自一家参考中心的数据

2026-06-120
OAAI
Metabolically healthy obesity is independently associated with 20-year incidence of cardiovascular disease: findings from the ATTICA cohort study (2002–2022)

代谢健康型肥胖与心血管疾病20年发病率独立相关:ATTICA队列研究(2002–2022)的发现

2026-04-180
OAAI
Guselkumab Improves Patient-Reported Outcomes Among Participants with Psoriatic Arthritis and Inadequate Response to Tumor Necrosis Factor Inhibitors in the COSMOS Study

在COSMOS研究中,Guselkumab可改善银屑病关节炎和对肿瘤坏死因子抑制剂反应不足的参与者的患者报告结局

2026-01-230
OAAI
The interplay of fibrinogen and lipoprotein(a) with 20-year atherosclerotic cardiovascular disease risk: a path analysis within the ATTICA study (2002–2022)

纤维蛋白原和脂蛋白(a)与20年动脉粥样硬化心血管疾病风险的相互作用:ATTICA研究(2002–2022)中的路径分析

2026-01-010
OAAI
Risk of major organ involvement in Behçet's patients with mucocutaneous onset: data from the AIDA Network Registry

贝赫切特病患者黏膜皮肤首发伴主要器官受累的风险:AIDA网络注册研究数据

2025-12-010
PRE